Stop Sepsis Through Home Monitoring Cooperative

NCT06920979 | Recruiting

• 2 other identifiers: EDGE003963Governement Health Belgium
• Study Type: interventional
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

In this study, patients presenting with acute infections at risk of developing sepsis will be followed in their home setting using wearables that provide (semi-)continue monitoring of vital signs as well as through follow up using a designated smartphone application. This is an innovative pilot study that will examine the potential of transmural care through telemonitoring for the first time in patients at risk for developing sepsis. By allowing for active follow-up of vital parameters in a transmural setting, this project aims to reduce the number of hospitalizations as compared to current practice. Furthermore, we aim to the number of patients referred to the emergency department after a visit at their primary care physician. Thereby, we aim to reduce the healthcare burden, yet providing the ability for rapid intervention in case of detarioration of patients, thereby reducing morbidity and mortality as well as associated costs.

Conditions

Sepsis; Home Monitoring Follow-up; Infection; Innovativeness

Outcome Measures

Primary Outcomes (4)

• Evaluation of the development and roll out of a central medical center for monitoring at home

  The total number of patients who use the home monitoring system for at least three days. This measure evaluates the adoption and feasibility of remote monitoring within a real-world setting.

  From enrollment to the end of monitoring depending on the clinical evolution of the patient, with a minimum of one week and a maximum follow-up of three weeks.

• Evaluation of the development and roll out of a central medical center for monitoring at home

  The proportion of patients whose wearable devices and smartphone applications successfully capture at least 80% of the required physiological data over the home monitoring period. This assesses the reliability and consistency of the telemonitoring system.

  From enrollment to the end of monitoring depending on the clinical evolution of the patient with a minimum follow-up of one week and up to a maximum of three weeks.

• Evaluation of the development and roll out of a central medical center for monitoring at home

  The effectiveness of telemonitoring wearables and smartphone applications in accurately measuring and tracking the National Early Warning Score (NEWS) in a home setting. This evaluates the clinical utility of remote patient monitoring for early detection of health deterioration.

  From enrollment to the end of monitoring depending on the clinical evolution of the patient with a minimum follow-up of one week and up to a maximum of three weeks of follow-up.

• Evaluation of the development and roll out of a central medical center for monitoring at home

  The number of emergency departments and primary care physicians actively using the telemonitoring platform to access and review patient data. This assesses the level of integration of home monitoring into routine clinical workflows.

  From enrollment to the end of monitoring depending on the clinical evolution of the patient with a minimum follow-up of one week and up to a maximum of three weeks of follow-up.

Study Arms (1)

(semi)continue monitoring of patients at risk for sepsis at home

OTHER

Patients with acute infections at risk of developing sespsis will be followed in their home setting using wearables that provide (semi-)continue monitoring of vital signs as well as through follow up using a desingated smarthphone application.

Other: (semi)continue monitoring of patients at risk for sepsis at home

Interventions

(semi)continue monitoring of patients at risk for sepsis at home OTHER

(semi)continue monitoring of patients at risk for sepsis at home

(semi)continue monitoring of patients at risk for sepsis at home

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• This study will include patients aged 18 years or older, capable of giving informed consent, presenting with signs of severe acute infection with a risk of developing sepsis at the emergency department or at their primary care physician.

You may not qualify if:

• Patients that are severely ill and require immediate hospitalization Qucik Sepsis Related Organ Failure score (QSOFA) ≥ 1 National Early Warning Score (NEWS) ≥ 5
• Patients that demonstrate confusion, changes in mental state and/or an Mini-Mental State Examination (MMSE) below 26
• Presence of neuropenic fever
• Patients currently undergoing immunosuppressive therapy or chemotherapy
• Patients with human immunodeficiency virus (HIV) or Acquired Immune Deficiency Syndrome (AIDS)
• Suspicion of appendicitis, suspicion of meningitis or meningeal irritation, suspicion of or high risk of developing endocarditis
• Complicated operation wounds at the time of screening
• Proven pneumonia (CURB 65 score ≥ 1)
• Emphysema, Chronic Obstructive Pulmonary Disease (COPD) GOLD \>1 or interstitial lung disease
• Patients with oxygen at home \> 2 l/min on a chronic basis (severe underlying lung disease?)
• Severe cardiovascular disease including:
• Severe heart failure New York Heart Association (NYHA) class \> 1
• Endoprosthesis
• Cardiac arrhythmia including atrial fibrillation
• Severe heart valve abnormalities

Sponsors & Collaborators

• University Hospital, Antwerp: lead

Study Sites (1)

Antwerp University Hospital (UZA)

Edegem, Antwerpen, 2650, Belgium

RECRUITING

MeSH Terms

Conditions

Sepsis; Infections

Condition Hierarchy (Ancestors)

Systemic Inflammatory Response Syndrome; Inflammation; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Celine Maes, PHD

CONTACT

+32 3 436 81 65; thuisopvolging@uza.be

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Clinical Professor

Study Record Dates

• First Submitted: March 19, 2025
• First Posted: April 10, 2025
• Study Start: February 1, 2025
• Primary Completion (Estimated): December 31, 2027
• Study Completion (Estimated): December 31, 2028
• Last Updated: May 1, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will share

Locations

BE (1)